Loading...
Personalized Peptide Therapies Will Drive Long-Term Biopharma Expansion
n/a
n/a
AnalystHighTarget's Fair Value
n/a
1Y
-45.5%7D
-2.2%1Y
-45.5%7D
-2.2%You can edit this narrative until Jul 29 9:23 PM. Then, changes will post as Updates.
You can edit this narrative until Jul 29 9:23 PM. Then, changes will post as Updates.